There is no legal duty to tell a patient they have been prescribed a drug ‘off label’.
Academic rigor, journalistic flair
Articles on Drug licenses
Displaying all articles
The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
Word that the U.S. has bought up the entire supply of the COVID-19 drug remdesivir is another reminder that in a pandemic, treatments and vaccines need to be accessible to everyone, globally.
In 2010, the European Ombudsman ruled that the European Medicines Agency should open access to clinical trials data when companies applied to get their drugs on the market. The ombudsman decided public…
Top contributors
-
Professor of Psychiatry, Bangor University
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Teaching Fellow in Pharmacy Practice, Kingston University
-
Assistant Professor, Resource Economics Dept., UMass Amherst
